ALVIO — Valerio Therapeutics SA Cashflow Statement
0.000.00%
Last trade - 00:00- €15.40m
- €17.56m
- €1.80m
Annual cashflow statement for Valerio Therapeutics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -33.7 | 1.09 | -5.94 | -19.6 | -20.3 |
| Depreciation | |||||
| Non-Cash Items | 0.964 | -8.37 | 0.042 | 0.77 | 2.26 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.329 | 2.6 | -3.19 | 9.35 | -0.509 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.7 | -4.68 | -8.57 | -9.44 | -18.6 |
| Capital Expenditures | -0.026 | -0.119 | -0.139 | -0.488 | -0.183 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.163 | 6.13 | 0.073 | 0.079 | 0.007 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.137 | 6.01 | -0.066 | -0.409 | -0.176 |
| Financing Cash Flow Items | 0 | -0.001 | 0.004 | 0.002 | -0.007 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.01 | 7.48 | 12 | 6.46 | 10.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5.54 | 8.81 | 3.36 | -3.3 | -7.77 |